Cargando…
Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children
BACKGROUND: Parainfluenza virus (PIV), a common pediatric pathogen, is associated with significant morbidity in immunocompromised (IC) hosts. DAS181, a novel sialidase fusion protein inhibitor, seems to be effective against PIV in vitro and in vivo; its use in IC children has not been evaluated. MET...
Autores principales: | Waghmare, Alpana, Wagner, Thor, Andrews, Robert, Smith, Sherilyn, Kuypers, Jane, Boeckh, Michael, Moss, Ronald, Englund, Janet A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501511/ https://www.ncbi.nlm.nih.gov/pubmed/26185620 http://dx.doi.org/10.1093/jpids/piu039 |
Ejemplares similares
-
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study
por: Chemaly, Roy F, et al.
Publicado: (2021) -
1715. A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Immunocompromised (IC) Patients With Parainfluenza Virus (PIV) Lower Respiratory Tract Infection (LRTI) on Supplemental Oxygen (SO)
por: Chemaly, Roy F, et al.
Publicado: (2018) -
Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State
por: Ogimi, Chikara, et al.
Publicado: (2018) -
Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome
por: Seo, Sachiko, et al.
Publicado: (2014) -
Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection
por: Waghmare, Alpana, et al.
Publicado: (2019)